SS Innovations Posts 117% Revenue Surge on Robotic Surgery Growth — SS Innovations International, Inc.

Event summary

Q1 2026 revenue jumped 116.8% YoY to $11.1M, with gross margin expanding to 48% from 21.2%.
SSi Mantra installations grew 73.3% YoY to 26, with cumulative surgeries reaching 9,744.
Company raised $18.6M in March 2026 private placement to fuel global expansion.
Regulatory approvals secured in Sri Lanka, Kenya, Indonesia, and the Philippines.
Net loss narrowed to $3.6M from $5.7M YoY, though still unprofitable.

The big picture

SS Innovations' explosive revenue growth reflects surging demand for affordable robotic surgery systems, particularly in emerging markets. The company's strategic focus on regulatory approvals and global expansion positions it to challenge Intuitive Surgical's dominance, though profitability remains elusive. Success hinges on sustaining installation momentum while navigating complex approval processes in high-value markets like the U.S. and EU.

What we're watching

Regulatory Milestones: Whether SS Innovations can secure FDA 510(k) clearance and EU CE marking in 2026, unlocking U.S. and European markets.
Market Penetration: The pace at which SSi Mantra installations grow in underserved countries and the Indian market.
Financial Sustainability: How the company balances aggressive expansion with narrowing losses amid rising R&D and SG&A expenses.